GeekWire
Menu
  • Home
  • News
    • Amazon
    • Civic presented by Microsoft
    • Geek Life presented by Network of Giving
    • Health/Life Sciences
    • Microsoft
    • Podcasts
    • Space
    • Startups
    • Sustainability
    • Tech Moves
    • Bot or Not
    • GeekWire on the Road: Spokane
    • Microsoft at 50 presented by Accenture
    • Tech Vets presented by Northern Trust
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • Amazon Office Buildings
    • GeekWire 200 presented by JPMorganChase
    • GeekWire Startup List
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • Nebius at NVIDIA GTC 2025 sponsored by Nebius
    • AWS Marketplace Seller Conference 2024 sponsored by AWS
    • AWS Summit: New York Partner Spotlights sponsored by AWS
    • Does Compute presented by Carnegie Mellon University
    • Guide to re:Invent sponsored by AWS
    • Money Hacks presented by BECU
    • Tech Connect at Dreamforce 2024 sponsored by RSM US LLP
    • Uncommon Thinkers Welcome sponsored by Greater Seattle Partners
    • Zuper at Inbound sponsored by Zuper
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
    • Sponsors
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What Happens Here Matters Everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Alder Biopharmaceuticals

Migraine drugmaker Alder Biopharmaceuticals to be acquired for nearly $2B by Lundbeck

Danish drugmaker Lundbeck is set to buy Bothell, Wash.-based Alder Biopharmaceuticals in a deal that could be worth up to… Read More

Tech Moves: OceanGate lands a COO; Alder hires chief commercial officer; and more

OceanGate, the maker of deep-sea submersibles, hired Robert Shuman as chief operating officer. Shuman previously held senior business roles at… Read More

Alder BioPharmaceuticals raises $170M in stock offering as FDA reviews its migraine therapy

Alder BioPharmaceuticals has raised $170 million in a stock offering and is ramping up operations after filing an FDA application… Read More

Tech Moves: Easy Metrics lands new CMO; Rakhi Voria jumps to IBM from Microsoft; and more

— Jill Keto signed on to be chief marketing officer at Easy Metrics, a supply chain operations startup that helps… Read More

Tech Moves: Alder gets a CFO; Eventcore snags sales VP; Redfin hires head of renovations

Carlos Campoy is the new CFO at Alder BioPharmaceuticals. The Bothell, Wash.-based drug company is developing eptinezumab, an antibody-based migraine… Read More

Tech Moves: Microsoft vets move to Amazon; NurseGrid expands executive team; and more

In one of two recent Microsoft-to-Amazon moves, Brian Schultz, who has worked on-and-off at Microsoft since 1999, is now working on… Read More

Tech Moves: Microsoft appoints new general counsel; Alder BioPharma poaches Amgen executive; and more

Microsoft has appointed longtime legal executive Dev Stahlkopf as its general counsel after leaving the position vacant for two years.… Read More

Alder BioPharma CEO and founder steps down as its lead migraine drug approaches FDA approval

News Brief: Randall Schatzman, the CEO and president of Bothell, Wash., company Alder BioPharmaceuticals, is stepping down from his role… Read More

Alder BioPharmaceuticals aims to raise $150M to continue developing migraine prevention drug

Alder BioPharmaceuticals is looking to raise approximately $150 million by selling off stock in order to continue work on a… Read More

Shares of Alder BioPharmaceuticals sink after Bristol-Myers Squibb deal falls apart

Shares of Alder BioPharmaceuticals continue to fall after the company received notice from partner Bristol-Myers Squibb Company after the giant drug company… Read More

Alder BioPharmaceuticals stock flat after unexciting IPO

Alder BioPharmaceuticals had a fairly ho-hum first day on Wall Street today. The Bothell-based biotech company’s stock closed at $10.03… Read More

A Word From Our Sponsors

About

  • About GeekWire
  • Contact Us
  • Partner With Us
  • Become a GeekWire Member
  • Send Us a Tip
  • Join Our Startup List
  • Reprints and Permissions

Follow

  • Facebook
  • X
  • LinkedIn
  • Instagram
  • RSS Feed
  • Podcast
  • YouTube
  • Bluesky

GeekWire Newsletters

Catch every headline in your inbox

Read GeekWire

  • Apple News
  • Google News

Legal

  • Privacy Policy
  • Terms of Use
  • Sponsored Content Policy
Return to Top of Page
© 2011-2025 GeekWire, LLC
Do Not Sell or Share My Personal information
Limit the Use Of My Sensitive Personal Information
Consent Preferences